RVMD
Revolution Medicines, Inc. (RVMD) reported revenue of $0.00 for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $0.00 | - |
| FY 2024 | $0.00 | -100.0% |
| FY 2023 | $11.58M | -67.3% |
| FY 2022 | $35.38M | +20.4% |
| FY 2021 | $29.39M | -31.6% |
| FY 2020 | $42.98M | -14.1% |
| FY 2019 | $50.04M | +148.2% |
| FY 2018 | $20.16M | - |
Revolution Medicines, Inc. (RVMD) reported revenue of $0.00 for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2018 and fiscal 2025, Revolution Medicines, Inc.'s revenue declined from $20.16M to $0.00.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.